Geert Cauwenbergh
Partner
Cancer
Legacy
Japan
Biography
Geert founded Barrier Therapeutics, a dermatology company in 2001. After bringing Barrier to success it was acquired by Stiefel in 2008. Prior to founding Barrier, Geert was responsible for the worldwide research and development of all skin care products for the Johnson & Johnson consumer companies. He is a board member of several dermatology companies. He has authored more than 100 publications. Geert is a shareholder of Legacy and acts as strategic and scientific advisor
Research Interest
Cancer
